These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38707833)

  • 21. The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait.
    Ali H; Naim M; Senum SR; AlSahow A; Bahbahani Y; Abu-Farha M; Abubaker J; Mohammad A; Al-Hunayan A; Asbeutah AM; Zayed M; Devarajan S; Hussain N; John SE; Channanath A; Thanaraj TA; Al-Ali M; AlMousawi M; Al-Mulla F; Harris PC
    Clin Kidney J; 2023 Feb; 16(2):355-366. PubMed ID: 36755831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome sequencing of Saudi Arabian patients with ADPKD.
    Al-Muhanna FA; Al-Rubaish AM; Vatte C; Mohiuddin SS; Cyrus C; Ahmad A; Shakil Akhtar M; Albezra MA; Alali RA; Almuhanna AF; Huang K; Wang L; Al-Kuwaiti F; Elsalamouni TSA; Al Hwiesh A; Huang X; Keating B; Li J; Lanktree MB; Al-Ali AK
    Ren Fail; 2019 Nov; 41(1):842-849. PubMed ID: 31488014
    [No Abstract]   [Full Text] [Related]  

  • 23. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
    Hoover E; Holliday V; Merullo N; Oberdhan D; Perrone RD; Rusconi C; Park M; Phadnis MA; Thewarapperuma N; Dahl NK
    Kidney Med; 2024 May; 6(5):100813. PubMed ID: 38689835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
    Sekine A; Hidaka S; Moriyama T; Shikida Y; Shimazu K; Ishikawa E; Uchiyama K; Kataoka H; Kawano H; Kurashige M; Sato M; Suwabe T; Nakatani S; Otsuka T; Kai H; Katayama K; Makabe S; Manabe S; Shimabukuro W; Nakanishi K; Nishio S; Hattanda F; Hanaoka K; Miura K; Hayashi H; Hoshino J; Tsuchiya K; Mochizuki T; Horie S; Narita I; Muto S
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of
    Ambrosini E; Montanari F; Cristalli CP; Capelli I; La Scola C; Pasini A; Graziano C
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.
    Lemoine H; Raud L; Foulquier F; Sayer JA; Lambert B; Olinger E; Lefèvre S; Knebelmann B; Harris PC; Trouvé P; Desprès A; Duneau G; Matignon M; Poyet A; Jourde-Chiche N; Guerrot D; Lemoine S; Seret G; Barroso-Gil M; Bingham C; Gilbert R; ; ; Le Meur Y; Audrézet MP; Cornec-Le Gall E
    Am J Hum Genet; 2022 Aug; 109(8):1484-1499. PubMed ID: 35896117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants.
    Nielsen ML; Lildballe DL; Rasmussen M; Bojesen A; Birn H; Sunde L
    Eur J Med Genet; 2021 Apr; 64(4):104183. PubMed ID: 33639313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Many lessons still to learn about autosomal dominant polycystic kidney disease.
    Orr S; Sayer JA
    J Rare Dis (Berlin); 2023; 2(1):13. PubMed ID: 37664187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations.
    Demetriou K; Tziakouri C; Anninou K; Eleftheriou A; Koptides M; Nicolaou A; Deltas CC; Pierides A
    Nephrol Dial Transplant; 2000 Feb; 15(2):205-11. PubMed ID: 10648666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.
    Izzi C; Dordoni C; Econimo L; Delbarba E; Grati FR; Martin E; Mazza C; Savoldi G; Rampoldi L; Alberici F; Scolari F
    Kidney Int Rep; 2020 Dec; 5(12):2341-2350. PubMed ID: 33305128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population data improves variant interpretation in autosomal dominant polycystic kidney disease.
    Mallawaarachchi AC; Furlong TJ; Shine J; Harris PC; Cowley MJ
    Genet Med; 2019 Jun; 21(6):1425-1434. PubMed ID: 30369598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history.
    Reed B; McFann K; Kimberling WJ; Pei Y; Gabow PA; Christopher K; Petersen E; Kelleher C; Fain PR; Johnson A; Schrier RW
    Am J Kidney Dis; 2008 Dec; 52(6):1042-50. PubMed ID: 18640754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
    Magistroni R; He N; Wang K; Andrew R; Johnson A; Gabow P; Dicks E; Parfrey P; Torra R; San-Millan JL; Coto E; Van Dijk M; Breuning M; Peters D; Bogdanova N; Ligabue G; Albertazzi A; Hateboer N; Demetriou K; Pierides A; Deltas C; St George-Hyslop P; Ravine D; Pei Y
    J Am Soc Nephrol; 2003 May; 14(5):1164-74. PubMed ID: 12707387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
    Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
    Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.
    Mantovani V; Bin S; Graziano C; Capelli I; Minardi R; Aiello V; Ambrosini E; Cristalli CP; Mattiaccio A; Pariali M; De Fanti S; Faletra F; Grosso E; Cantone R; Mancini E; Mencarelli F; Pasini A; Wischmeijer A; Sciascia N; Seri M; La Manna G
    Front Genet; 2020; 11():464. PubMed ID: 32457805
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: a single-center, 20-year review.
    Tee JB; Acott PD; McLellan DH; Crocker JF
    Am J Kidney Dis; 2004 Feb; 43(2):296-303. PubMed ID: 14750095
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Besse W; Chang AR; Luo JZ; Triffo WJ; Moore BS; Gulati A; Hartzel DN; Mane S; ; Torres VE; Somlo S; Mirshahi T
    J Am Soc Nephrol; 2019 Nov; 30(11):2091-2102. PubMed ID: 31395617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
    Kingdom R; Wright CF
    Front Genet; 2022; 13():920390. PubMed ID: 35983412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.